Complete financial analysis of Pangaea Oncology, S.A. (PANG.MC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pangaea Oncology, S.A., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- City of London Investment Group PLC (CLIUF) Income Statement Analysis – Financial Results
- NDL Ventures Limited (NDLVENTURE.BO) Income Statement Analysis – Financial Results
- Maanshan Iron & Steel Company Limited (0323.HK) Income Statement Analysis – Financial Results
- Bharat Heavy Electricals Limited (BHEL.NS) Income Statement Analysis – Financial Results
- Deep Field Technologies, Inc. (DPFD) Income Statement Analysis – Financial Results
Pangaea Oncology, S.A. (PANG.MC)
About Pangaea Oncology, S.A.
Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries. The company offers molecular diagnostics, such as mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression; clinical trials; in vitro drug profiling, including MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing; and Dx platform, which performs companion diagnostic platform validation, validation against commercially available platforms, and Ad-hoc R+D for diagnostics companies. It also provides biomarker discovery to identify novel targets for targeted therapies in pre-clinical development. Pangaea Oncology, S.A. was founded in 2006 and is based in Barcelona, Spain.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.00M | 4.37M | 4.60M | 4.10M | 3.32M | 3.06M | 2.62M | 2.52M | 1.95M | 1.72M | 3.09M |
| Cost of Revenue | 244.86K | 255.54K | -568.61K | -512.72K | -1.09M | -1.23M | -851.69K | -1.89M | -717.95K | -335.76K | -393.56K |
| Gross Profit | 7.75M | 4.11M | 5.17M | 4.61M | 4.41M | 4.29M | 3.47M | 4.41M | 2.67M | 2.05M | 3.48M |
| Gross Profit Ratio | 96.94% | 94.15% | 112.35% | 112.51% | 132.93% | 140.28% | 132.49% | 175.11% | 136.83% | 119.55% | 112.74% |
| Research & Development | 1.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 9.17M | 1.21M | 761.39K | 1.21M | 1.24M | 1.39M | 1.64M | 1.43M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 176.48K | 71.29K | 25.46K | 11.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.35M | 1.28M | 786.86K | 1.21M | 1.24M | 1.39M | 1.64M | 1.43M | 0.00 | 0.00 | 0.00 |
| Other Expenses | 1.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 11.38M | 6.31M | 5.47M | 6.28M | 6.70M | 6.24M | 6.07M | 4.95M | 3.66M | 3.12M | 3.27M |
| Cost & Expenses | 13.78M | 6.57M | 4.90M | 5.76M | 5.61M | 5.00M | 5.22M | 3.06M | 2.94M | 2.78M | 2.88M |
| Interest Income | 124.77K | 19.73K | 1.90K | 0.00 | 0.00 | 677.00 | 5.54K | 1.29K | 66.85K | 0.00 | 0.00 |
| Interest Expense | 133.94K | 189.41K | 252.91K | 186.03K | 190.78K | 346.79K | 295.30K | 260.26K | 192.45K | 118.50K | 115.78K |
| Depreciation & Amortization | 1.82M | 1.24M | 992.28K | 2.41M | 3.08M | 2.52M | 1.95M | 1.24M | 855.36K | 680.19K | 449.22K |
| EBITDA | -1.56M | -1.41M | 146.78K | 730.31K | -1.71M | 739.85K | -903.59K | -231.70K | 558.92K | -308.96K | 740.37K |
| EBITDA Ratio | -19.47% | -26.92% | 7.94% | 16.79% | 23.66% | 18.84% | -25.13% | 27.70% | -2.91% | -17.99% | 23.97% |
| Operating Income | -3.82M | 2.56M | -532.97K | -1.66M | -4.79M | -1.78M | -2.71M | -542.56K | -974.66K | -1.07M | 209.94K |
| Operating Income Ratio | -47.77% | 58.58% | -11.58% | -40.60% | -144.51% | -58.29% | -103.31% | -21.55% | -50.00% | -62.09% | 6.80% |
| Total Other Income/Expenses | 314.08K | -280.40K | -565.45K | -242.68K | -191.78K | -345.97K | -439.67K | -241.06K | -136.36K | -43.51K | -34.58K |
| Income Before Tax | -3.51M | -2.84M | -1.10M | -1.91M | -4.98M | -2.13M | -3.15M | -1.73M | -1.11M | -1.11M | 175.37K |
| Income Before Tax Ratio | -43.84% | -65.00% | -23.86% | -46.52% | -150.30% | -69.60% | -120.08% | -68.78% | -56.99% | -64.62% | 5.68% |
| Income Tax Expense | 1.29M | -114.71K | -456.51K | -112.68K | -143.88K | -875.71K | -1.50M | -1.14M | -624.66K | -913.29K | 97.97K |
| Net Income | -4.66M | -2.71M | -641.91K | -1.79M | -4.84M | -1.25M | -1.65M | -594.53K | -486.36K | -196.39K | 77.40K |
| Net Income Ratio | -58.22% | -62.09% | -13.94% | -43.77% | -145.96% | -40.96% | -62.82% | -23.61% | -24.95% | -11.44% | 2.51% |
| EPS | -0.15 | -0.09 | -0.03 | -0.09 | -0.28 | -0.09 | -0.15 | -0.06 | -0.05 | -0.02 | 0.01 |
| EPS Diluted | -0.15 | -0.09 | -0.03 | -0.09 | -0.28 | -0.09 | -0.15 | -0.06 | -0.05 | -0.02 | 0.01 |
| Weighted Avg Shares Out | 30.14M | 30.44M | 22.82M | 19.00M | 17.14M | 13.30M | 10.77M | 10.77M | 10.77M | 10.77M | 10.77M |
| Weighted Avg Shares Out (Dil) | 30.14M | 30.44M | 22.82M | 19.00M | 17.14M | 13.30M | 10.77M | 10.77M | 10.77M | 10.77M | 10.77M |
Source: https://incomestatements.info
Category: Stock Reports